GENSPEED Biotech: Novel Point-of-Care Testing Technology Enables Rapid Test for Medical Risk Classification
RAINBACH, Austria--(BUSINESS WIRE)--Feb 20, 2019--Austrian GENSPEED Biotech GmbH and Virogates A/S (Nasdaq First North Denmark: VIRO) have commenced a partnership to develop a rapi…
